• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光果甘草提取物和槲皮素通过抑制细胞色素P450 1B1酶逆转三阴性MDA-MB-468乳腺癌细胞的顺铂耐药性。

Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.

作者信息

Sharma Rajni, Gatchie Linda, Williams Ibidapo S, Jain Shreyans K, Vishwakarma Ram A, Chaudhuri Bhabatosh, Bharate Sandip B

机构信息

Natural Products Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India; Academy of Scientific & Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.

Leicester School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK.

出版信息

Bioorg Med Chem Lett. 2017 Dec 15;27(24):5400-5403. doi: 10.1016/j.bmcl.2017.11.013. Epub 2017 Nov 7.

DOI:10.1016/j.bmcl.2017.11.013
PMID:29150398
Abstract

The development of multi-drug resistance to existing anticancer drugs is one of the major challenges in cancer treatment. The over-expression of cytochrome P450 1B1 enzyme has been reported to cause resistance to cisplatin. With an objective to discover cisplatin-resistance reversal agents, herein, we report the evaluation of Glycyrrhiza glabra (licorice) extracts and its twelve chemical constituents for inhibition of CYP1B1 (and CYP1A1) enzyme in Sacchrosomes and live human cells. The hydroalcoholic extract showed potent inhibition of CYP1B1 in both Sacchrosomes as well as in live cells with IC values of 21 and 16 µg/mL, respectively. Amongst the total of 12 constituents tested, quercetin and glabrol showed inhibition of CYP1B1 in live cell assay with IC values of 2.2 and 15 µM, respectively. Both these natural products were found to be selective inhibitors of CYP1B1, and does not inhibit CYP2 and CYP3 family of enzymes (IC > 20 µM). The hydroalcoholic extract of G. glabra and quercetin (4) showed complete reversal of cisplatin resistance in CYP1B1 overexpressing triple negative MDA-MB-468 breast cancer cells. The selective inhibition of CYP1B1 by quercetin and glabrol over CYP2 and CYP3 family of enzymes was studied by molecular modeling studies.

摘要

对现有抗癌药物产生多药耐药性是癌症治疗中的主要挑战之一。据报道,细胞色素P450 1B1酶的过度表达会导致对顺铂产生耐药性。为了发现顺铂耐药逆转剂,在此我们报告了光果甘草提取物及其12种化学成分对线粒体微粒体和活的人类细胞中CYP1B1(和CYP1A1)酶的抑制作用评估。水醇提取物在微粒体和活细胞中均显示出对CYP1B1的有效抑制作用,IC值分别为21和16μg/mL。在总共测试的12种成分中,槲皮素和光甘草醇在活细胞测定中对CYP1B1有抑制作用,IC值分别为2.2和15μM。发现这两种天然产物都是CYP1B1的选择性抑制剂,不抑制CYP2和CYP3酶家族(IC>20μM)。光果甘草的水醇提取物和槲皮素(4)在过表达CYP1B1的三阴性MDA-MB-468乳腺癌细胞中显示出顺铂耐药性的完全逆转。通过分子建模研究了槲皮素和光甘草醇对CYP2和CYP3酶家族的CYP1B1选择性抑制作用。

相似文献

1
Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.光果甘草提取物和槲皮素通过抑制细胞色素P450 1B1酶逆转三阴性MDA-MB-468乳腺癌细胞的顺铂耐药性。
Bioorg Med Chem Lett. 2017 Dec 15;27(24):5400-5403. doi: 10.1016/j.bmcl.2017.11.013. Epub 2017 Nov 7.
2
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.基于吡咯的查耳酮作为CYP1酶抑制剂的合成及生物学评价,用于癌症的可能预防及克服顺铂耐药性
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3683-3687. doi: 10.1016/j.bmcl.2017.07.010. Epub 2017 Jul 4.
3
CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.CYP 酶在活的人体悬浮细胞中表达,优于广泛使用的微粒体酶,可用于鉴定强效 CYP1A1/CYP1B1 抑制剂:鉴定出喹唑啉酮类化合物是 CYP1A1/CYP1B1 抑制剂,可有效逆转 B[a]P 毒性和顺铂耐药性。
Eur J Pharm Sci. 2019 Apr 1;131:177-194. doi: 10.1016/j.ejps.2019.02.016. Epub 2019 Feb 15.
4
Quinazoline derivatives as selective CYP1B1 inhibitors.喹唑啉衍生物作为选择性 CYP1B1 抑制剂。
Eur J Med Chem. 2017 Apr 21;130:320-327. doi: 10.1016/j.ejmech.2017.02.032. Epub 2017 Feb 16.
5
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.新型α-萘黄酮作为细胞色素P450(CYP)1B1抑制剂的设计与合成,以克服与CYP1B1过表达相关的多西他赛耐药性。
J Med Chem. 2015 Apr 23;58(8):3534-47. doi: 10.1021/acs.jmedchem.5b00265. Epub 2015 Apr 1.
6
Evidence for Chemopreventive and Resilience Activity of Licorice: and G. Extracts Modulate Estrogen Metabolism in ACI Rats.甘草和葛花提取物对 ACI 大鼠雌激素代谢的调节作用及其化学预防和抗应激活性的证据。
Cancer Prev Res (Phila). 2018 Dec;11(12):819-830. doi: 10.1158/1940-6207.CAPR-18-0178. Epub 2018 Oct 4.
7
Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.蜜桔素通过 CYP1A1/CYP1B1 酶诱导和 CYP1A1/CYP1B1 介导的代谢转化为产物 4' 羟基蜜桔素来抑制人乳腺癌细胞的增殖。
Toxicol In Vitro. 2018 Aug;50:274-284. doi: 10.1016/j.tiv.2018.04.001. Epub 2018 Apr 4.
8
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.基于杂环查耳酮的新型CYP1B1抑制剂的发现与表征:克服CYP1B1过表达细胞系中的顺铂耐药性
Eur J Med Chem. 2017 Mar 31;129:159-174. doi: 10.1016/j.ejmech.2017.02.016. Epub 2017 Feb 9.
9
Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.银杏叶提取物对致癌物前体生物激活的人CYP1酶的影响:异鼠李素、山奈酚和槲皮素作为CYP1B1有效抑制剂的鉴定。
Toxicol Appl Pharmacol. 2006 May 15;213(1):18-26. doi: 10.1016/j.taap.2005.09.007. Epub 2005 Oct 14.
10
Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.克服 A549 细胞中的紫杉醇耐药性:通过 4-羟基大黄素靶向 P-糖蛋白转运体、AKT/ERK 通路和细胞色素 P450 酶 CYP1B1 的综合策略。
Biochem Pharmacol. 2020 Jan;171:113733. doi: 10.1016/j.bcp.2019.113733. Epub 2019 Nov 26.

引用本文的文献

1
Breast Cancer Cytochromes P450: Chemopreventive and/or Therapeutic Targets for Naturally Occurring Phytochemicals.乳腺癌细胞色素P450:天然植物化学物质的化学预防和/或治疗靶点
Molecules. 2025 Jul 23;30(15):3079. doi: 10.3390/molecules30153079.
2
Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides-Current Developments in Structure-Activity Relationship.金属药物和金属化宿主防御肽的抗癌活性-结构-活性关系的最新进展。
Int J Mol Sci. 2024 Jul 3;25(13):7314. doi: 10.3390/ijms25137314.
3
Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
阳营活血汤通过 PI3K/AKT 通路对肝纤维化大鼠模型的治疗作用:基于网络药理学和分子对接。
Aging (Albany NY). 2024 Feb 15;16(4):3773-3789. doi: 10.18632/aging.205559.
4
Application of Polyphenols and Flavonoids in Oncological Therapy.多酚和类黄酮在肿瘤治疗中的应用。
Molecules. 2023 May 13;28(10):4080. doi: 10.3390/molecules28104080.
5
Design of Cytochrome P450 1B1 Inhibitors a Scaffold-Hopping Approach.细胞色素P450 1B1抑制剂的设计——一种骨架跃迁方法
J Med Chem. 2023 Jan 12;66(1):398-412. doi: 10.1021/acs.jmedchem.2c01368. Epub 2022 Dec 15.
6
Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.甘草膳食补充剂对女性参与者细胞色素 P450 酶的药代动力学相互作用。
Drug Metab Dispos. 2023 Feb;51(2):199-204. doi: 10.1124/dmd.122.001050. Epub 2022 Nov 3.
7
CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells.CYP1B1 增强三阴性乳腺癌细胞的间充质、Claudin-Low 和化疗耐药表型。
Int J Mol Sci. 2022 Aug 26;23(17):9670. doi: 10.3390/ijms23179670.
8
Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments.铂和钯配合物作为抗肿瘤治疗的有前途的来源。
Int J Mol Sci. 2021 Jul 31;22(15):8271. doi: 10.3390/ijms22158271.
9
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy.我们对顺铂在癌症治疗中作用分子机制的认识进展
J Exp Pharmacol. 2021 Mar 18;13:303-328. doi: 10.2147/JEP.S267383. eCollection 2021.
10
A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer Treatment.FDY003治疗乳腺癌分子机制的网络药理学研究
Evid Based Complement Alternat Med. 2021 Feb 6;2021:3919143. doi: 10.1155/2021/3919143. eCollection 2021.